Taiwan FDA registration abb1339979c21c873aeeaa410674c359
"KAWASUMI" BLOOD SEPARATOR
TW: "川澄"自動血漿壓板系統
Taiwan·Risk Class 2·MD·LMB TECHNOLOGIE GMBH·Registered Apr 17, 2018 – Apr 17, 2023ExpiredRegistration details
- Analysis ID
- abb1339979c21c873aeeaa410674c359
- License Form
- Ministry of Health Medical Device Import No. 030541
- Customs Code
- DHA05603054105
Company information
- Manufacturer
- LMB TECHNOLOGIE GMBH
- Manufacturer Country
- Germany
- Authorized Representative
- K2 INTERNATIONAL MEDICAL INC.
Product details
- Intended Use
- This system is a device used by blood banks and transfusion centers to automatically separate blood components. Red blood cells, plasma, platelets, precipitated brown-yellow layer, frozen precipitate and other components can be separated from whole blood after centrifugation.
- Product Type (Level 1)
- B Hematology and pathology devices
- Product Type (Level 2)
- B0002 Blood component extraction device
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Apr 17, 2018
- Expiry Date
- Apr 17, 2023
About this record
Access comprehensive regulatory information for "KAWASUMI" BLOOD SEPARATOR in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number abb1339979c21c873aeeaa410674c359 and manufactured by LMB TECHNOLOGIE GMBH. The authorized representative in Taiwan is K2 INTERNATIONAL MEDICAL INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices